LONDON: Apollon Formularies (AQSE: APOL) has signed a joint venture agreement with Tri-Medi Canna, a South African based medical cannabis company, to establish a jointly-owned incorporated South African company, Apollon SA Pty Ltd. The Joint Venture has an initial contract term of 12 months and shall be governed by a definitive joint venture agreement. Apollon…